The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis.

by François M J Lamoury, Brendan Jacka, Sofia Bartlett, Rowena A Bull, Arthur Wong, Janaki Amin, Janke Schinkel, Art F Poon, Gail V Matthews, Jason Grebely, Gregory J Dore, Tanya L Applegate
Published 2015-01-01

Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial

by Jason Grebely, Phillip Read, Evan B. Cunningham, Martin Weltman, Gail V. Matthews, Adrian Dunlop, Mark Montebello, Marianne Martinello, Rosie Gilliver, Philippa Marks, Tanya L. Applegate, Gregory J. Dore, the DARLO‐C Study Group
Published 2020-06-01

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.

by Daniel Bradshaw, Jayna Raghwani, Brendan Jacka, Rachel Sacks-Davis, Francois Lamoury, Ian Down, Garrett Prestage, Tanya L Applegate, Margaret Hellard, Joe Sasadeusz, Gregory J Dore, Oliver G Pybus, Gail V Matthews, Mark Danta
Published 2016-01-01

Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

by David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, Anupriya Aggarwal, Malinna Yeang, Anna Condylios, Anthony D. Kelleher, Tanya L. Applegate, Andrew Vallely, David Whiley, William Rawlinson, Phillip Cunningham, John Kaldor, Rebecca Guy
Published 2020-10-01

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

by Mark W. Douglas, Enoch S.E. Tay, Dao Sen Wang, Adrian T.L. Ong, Caroline Wilson, Amy Phu, Jen Kok, Dominic E. Dwyer, Rowena A. Bull, Andrew R. Lloyd, Tanya L. Applegate, Gregory J. Dore, Anita Y. Howe, Richard Harrigan, Jacob George
Published 2020-06-01

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

by Evan B. Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S. Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw, Adrian Dunlop, Julie Bruneau, Håvard Midgard, Stefan Bourgeois, Maria Christine Thurnheer, Gregory J Dore, Jason Grebely, on behalf of the ACTIVATE Study Group
Published 2017-06-01

The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial

by Ye Zhang, Mph, Muhammad S Jamil, PhD, Kirsty S Smith, PhD, Tanya L Applegate, PhD, Garrett Prestage, PhD., Martin Holt, PhD, Phillip Keen, BA, Benjamin R Bavinton, PhD, Marcus Chen, PhD, Damian P Conway, PhD, Handan Wand, PhD, Anna M McNulty, MMed, Darren Russell, PhD, Matthew Vaughan, MS, Colin Batrouney, BA, Virginia Wiseman, PhD, Christopher K Fairley, PhD, Andrew E Grulich, PhD, Matthew Law, PhD, John M Kaldor, PhD, Rebecca J Guy, PhD
Published 2021-09-01